AU2002225702A1 - Method to identify genes associated with chronic myelogenous leukemia - Google Patents

Method to identify genes associated with chronic myelogenous leukemia

Info

Publication number
AU2002225702A1
AU2002225702A1 AU2002225702A AU2570202A AU2002225702A1 AU 2002225702 A1 AU2002225702 A1 AU 2002225702A1 AU 2002225702 A AU2002225702 A AU 2002225702A AU 2570202 A AU2570202 A AU 2570202A AU 2002225702 A1 AU2002225702 A1 AU 2002225702A1
Authority
AU
Australia
Prior art keywords
myelogenous leukemia
chronic myelogenous
genes associated
identify genes
identify
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002225702A
Inventor
Huilin Qi
Stephanie Salesse
Catherine M. Verfaillie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota filed Critical University of Minnesota
Publication of AU2002225702A1 publication Critical patent/AU2002225702A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002225702A 2000-11-14 2001-11-14 Method to identify genes associated with chronic myelogenous leukemia Abandoned AU2002225702A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24840300P 2000-11-14 2000-11-14
US60/248,403 2000-11-14
PCT/US2001/043781 WO2002040718A2 (en) 2000-11-14 2001-11-14 Method to identify genes associated with chronic myelogenous leukemia

Publications (1)

Publication Number Publication Date
AU2002225702A1 true AU2002225702A1 (en) 2002-05-27

Family

ID=22938960

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002225702A Abandoned AU2002225702A1 (en) 2000-11-14 2001-11-14 Method to identify genes associated with chronic myelogenous leukemia

Country Status (4)

Country Link
EP (1) EP1399586A2 (en)
AU (1) AU2002225702A1 (en)
CA (1) CA2428716A1 (en)
WO (1) WO2002040718A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449548B2 (en) 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
WO2005014853A1 (en) * 2003-07-28 2005-02-17 Universität Bremen Comparative expression analysis for the identification of genes responsible for phenotypic differences

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207412B1 (en) * 1997-11-13 2001-03-27 The Regents Of The University Of California Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells

Also Published As

Publication number Publication date
WO2002040718A2 (en) 2002-05-23
CA2428716A1 (en) 2002-05-23
WO2002040718A3 (en) 2003-12-31
EP1399586A2 (en) 2004-03-24

Similar Documents

Publication Publication Date Title
AU2001288476A1 (en) Genes involved in isoprenoid compound production
AU2002249802A1 (en) Decorative laminate
AU2002211431A1 (en) Bleed-resistant dry-transfer wallcoverings
AU2001244570A1 (en) Writing implement
AU2001293309A1 (en) Crosstalk reduction in constrained wiring assemblies
AUPS078002A0 (en) Dnazyme therapeutics
EP1434867A4 (en) Genes involved in isoprenoid compound production
AU2001255797A1 (en) Enhanced gene expression in plants using transcription factors
AUPQ905800A0 (en) Rendering page descriptions
AU2001243642A1 (en) Transcription factors
AU2001240103A1 (en) Reproduction-specific genes
AU2002225702A1 (en) Method to identify genes associated with chronic myelogenous leukemia
AUPQ844100A0 (en) Stacking rack
AU2001266176A1 (en) Methods
AU2001286212A1 (en) Rare-earth ternary complex
AU2001240024A1 (en) Camptothecin complexes
AU2002320853A1 (en) Front surface rail
AU2458201A (en) Spf1-related transcription factors
AU2001250536A1 (en) Methods
AU2001292445A1 (en) Straight guide
AU2001241080A1 (en) Mouse adipocyte-origin genes
AU2001235986A1 (en) Method of detecting chronic myelogenous leukemia
AU2001268466A1 (en) 55p4h4: gene expressed in various cancers
AU2001221475A1 (en) Wood air-brick
AU2002212379A1 (en) Core structure